Vor Biopharma Inc VOR:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/03/21 EST
40.05quote price arrow down-2.54 (-5.96%)
Volume
268,542
52 week range
25.32 - 63.62

...

Loading . . .

KEY STATS

  • Open43.58
  • Day High43.83
  • Day Low38.49
  • Prev Close40.05
  • 52 Week High63.62
  • 52 Week High Date02/05/21
  • 52 Week Low25.32
  • 52 Week Low Date02/05/21
  • Market Cap1.428B
  • Shares Out35.65M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.35
  • P/E (TTM)-113.20
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-31.227M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Vor Biopharma Inc News

There is no recent news for this security.

Latest VOR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Vor Biopharma Inc is a clinical-stage cell therapy company. The Company is engaged in combining a novel patient engineering approach with targeted therapies to provide solution for patients suffering from hematological malignancies. The Company develops engineered hematopoietic stem cell (eHSC) product candidate, VOR33, VCAR33, which together are the treatment paradigm for acute myeloid leukemia (AML) and other hematological malignancies. The Company’s platform provides...
Address
215 First Street, Suite 430
Cambridge, MA
02142
United States